amgen maritide glp-1 drug comparison Development Progress and Prospects of Antibody-Peptide Conjugates GLP-1 Receptor Agonist Shortage: Challenges

But in an older population, we are cautious with this drug and any immunosuppressive therapies due to the risk of infection

On the other hand, the immediate price tag is hard to ignore

Digestive efficiency, gut health and individual metabolism all influence oral bioavailability

Emerging evidence suggests that MetS contributes to pain catastrophizing, with obesity acting as a key amplifier of pain perception in inflammatory diseases such as PsA ( In addition to psoriatic disease, GLP-1RAs are currently under investigation in other immune-mediated inflammatory diseases (IMIDs), such as inflammatory bowel disease, RA, and systemic lupus erythematosus ( Several clinical trials registered on ClinicalTrials.gov support the growing scientific interest in the repurposing of GLP-1RAs for psoriatic disease